Compare GLNG & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLNG | TWST |
|---|---|---|
| Founded | 1946 | 2013 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.2B |
| IPO Year | 2002 | 2018 |
| Metric | GLNG | TWST |
|---|---|---|
| Price | $49.73 | $94.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $50.63 | $46.88 |
| AVG Volume (30 Days) | 992.1K | ★ 1.9M |
| Earning Date | 11-21-2023 | 05-04-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $3.14 | $18.91 |
| Revenue Next Year | $8.66 | $15.07 |
| P/E Ratio | $80.48 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $35.02 | $23.30 |
| 52 Week High | $57.79 | $105.47 |
| Indicator | GLNG | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 47.67 | 55.61 |
| Support Level | $48.50 | $87.57 |
| Resistance Level | $51.99 | $105.47 |
| Average True Range (ATR) | 1.26 | 6.78 |
| MACD | -0.00 | -1.23 |
| Stochastic Oscillator | 46.19 | 41.12 |
Golar LNG Ltd designs, converts, owns, and operates marine infrastructure for the liquefaction of natural gas and provides floating liquefied natural gas (FLNG) services. It offers solutions for gas resource holders to develop and utilize gas reserves, including stranded, associated, flared, or underutilized resources. The company's reportable segments are: i) FLNG: includes the operations of FLNG vessels and projects, and ii) Corporate and other: includes legacy shipping segment activities, vessel management, floating storage and regasification unit services for third parties. The majority of the company's revenue is derived from the FLNG segment. Geographically, it generates the maximum revenue from Cameroon.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.